Navigation Links
Eurofins Genomics US Announces Commercial Launch of Next Generation DNA Synthesis Service
Date:3/14/2017

LOUISVILLE, Ky., March 14, 2017 /PRNewswire/ -- Eurofins Genomics, the pioneer of high-throughput oligonucleotide synthesis, announced the U.S. commercial launch of a unique DNA synthesis service based on the company's revolutionary next-generation synthesis platform. The service, which is designed to supply small quantities of high-quality oligos for use in molecular biology and synthetic biology, among other applications, allows users to receive high-fidelity, QC-verified oligos for low cost and with industry-leading turnaround.

Standard approaches to synthesizing oligonucleotides—commonly used as primers for PCR, qPCR, and next-generation sequencing-based workflows—produce much more DNA than scientists need, forcing them to pay for excess material that will never be used. The new Eurofins Genomics synthesis platform was engineered for scalability, producing both small synthesis scale (down to 0.5 nanomoles) to very large orders of DNA. By allowing scientists to choose how much DNA to buy, this service will reduce costs and enable users to perform more experiments on the same budget.

Eurofins Genomics has made a series of recent improvements to its oligo synthesis services. In the U.S. and Canada, orders for oligos meeting the specified scale, length and purification criteria and placed as late as 5:00 p.m. are eligible for same-day synthesis and overnight shipping for no additional surcharge. The company also launched EXTREmer oligonucleotides, extremely long oligos produced at low yield and with low error rates, which are ideal for synthetic biology and CRISPR experiments. In addition, the company has expanded the hours of operation for its service lab to include Sundays, so is now running seven days a week and virtually around the clock to ensure reliability for customers.   

"By completely reimagining the synthesis process, including applying tenants of aerospace engineering, we have created a new platform that will help users accelerate their science while ensuring the quality and reliability of their results," said Martin Kunz, President, Eurofins Genomics US. "We have been very encouraged by feedback about our next-generation synthesis technology from customers in our beta program and are pleased to expand its availability to more scientists in the U.S."

To learn more about all of the products and services offered by Eurofins Genomics, visit www.eurofinsgenomics.com.

About Eurofins Genomics

Eurofins Genomics company is an international provider of DNA sequencing services, genotyping services, DNA synthesis products, and bioinformatics services for pharma, diagnostics, food, agriculture, biotechnological, and research markets. Eurofins Genomics operates leading R&D and production sites in the USA, Canada, Germany, India, and Japan.

Eurofins Genomics is the genomic services brand of the Eurofins Group, the worldwide leader in food, environmental and pharmaceutical testing. With EUR 2.54 billion in annual revenues and over 27,000 employees across over 310 sites in 39 countries, Eurofins Scientific is a leading international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.

© Eurofins MWG Operon, LLC. A Eurofins Genomics Company

Contacts:

Media:
Nicole Litchfield
Bioscribe, Inc.
415-793-6468
nicole@bioscribe.com

Company:
James Corne
Eurofins Genomics
502-302-6351
jamescorne@eurofins.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/eurofins-genomics-us-announces-commercial-launch-of-next-generation-dna-synthesis-service-300423119.html


'/>"/>
SOURCE Eurofins Genomics
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Express Genes by Eurofins MWG Operon Offers 4 Day Delivery of Synthetic Genes
2. SimpleSeq Webless by Eurofins MWG Operon for Order-Free DNA Sequencing
3. Eurofins MWG Operon Quality Assurance Group Completes ISO Certifications for Their New Overnight Sequencing Lab
4. Eurofins MWG Operon, Inc. Names James Corne as Director of Marketing
5. Eurofins Pharma Discovery Services Launches New eCommerce Platform for Drug Discovery Products
6. Eurofins Microbiology Opens State-of-the-Art Laboratory in Louisville, KY
7. Eurofins Genomics Looks to Disrupt DNA Synthesis Market with Smaller-Scale, High-Throughput Service Featuring Rapid Turnaround and Lower Price
8. Clarification on Eurofins Scientific, Inc. (US) Announcement of the Appointment of Sean Murray
9. Eurofins Genomics Launches EXTREmers - Extremely Long Oligonucleotides
10. Eurofins Genomics Expands Express Oligo Service
11. Genomics Data Management Leader Annai Systems Offers Shortcut to Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... USA (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s ... take place on 7th and 8th June 2018 in San Francisco, CA. The Summit ... as well as several distinguished CEOs, board directors and government officials from around the ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... ... October 10, 2017 , ... For ... has won a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled ... Volunteer Experience from US2020. , US2020’s mission is to change the trajectory of ...
Breaking Biology Technology:
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced ... will feature emerging and evolving technology through ... Innovation Summits will run alongside the expo portion of ... sessions, panels and demonstrations focused on trending topics within ... advanced design and manufacturing event will take place June ...
(Date:4/11/2017)... April 11, 2017 No two people ... at the New York University Tandon School of ... have found that partial similarities between prints are ... in mobile phones and other electronic devices can ... The vulnerability lies in the fact that fingerprint-based ...
(Date:4/5/2017)... , April 5, 2017 Today ... announcing that the server component of the HYPR platform ... for providing the end-to-end security architecture that empowers biometric ... HYPR has already secured over 15 million users ... including manufacturers of connected home product suites and physical ...
Breaking Biology News(10 mins):